Page last updated: 2024-10-27

gabexate and Thrombophilia

gabexate has been researched along with Thrombophilia in 1 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Thrombophilia: A disorder of HEMOSTASIS in which there is a tendency for the occurrence of THROMBOSIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tomita, N1
Kanamori, H1
Fujita, H1
Maruta, A1
Naitoh, A1
Nakamura, S1
Ota, Y1
Nozue, N1
Kihara, M1
Ishigatsubo, Y1

Other Studies

1 other study available for gabexate and Thrombophilia

ArticleYear
Granulomatous tubulointerstitial nephritis induced by all-trans retinoic acid.
    Anti-cancer drugs, 2001, Volume: 12, Issue:8

    Topics: Aged; Benzamidines; Dalteparin; Drug Administration Schedule; Gabexate; Guanidines; Humans; Idarubic

2001